Related Experiment Video
Updated: Aug 8, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Analysis of mitochondrial DNA mutations in Pakistani population diagnosed with cardiovascular diseases
1Dalian Medical University, Department of Cell Biology, Dalian, Liaoning, China.
Insights
This study found no mutations in mitochondrial Leucine Transfer RNA genes (MT-TL1 and MT-TL2) in Pakistani cardiovascular disease (CVD) patients. Further research on larger populations and other mitochondrial genes is recommended for early CVD genetic screening.
Area of Science:
- Genetics
- Cardiology
- Mitochondrial Biology
Background:
- Cardiovascular disease (CVD) encompasses various heart and blood vessel disorders.
- Mitochondrial DNA mutations are increasingly implicated in complex diseases.
- The role of specific mitochondrial genes in CVD pathogenesis requires further investigation.
Purpose of the Study:
- To investigate the association between mitochondrial Leucine Transfer RNA genes (MT-TL1 and MT-TL2) and cardiovascular disease (CVD).
- To screen for mutations in MT-TL1 and MT-TL2 genes in a cohort of CVD patients from Peshawar, Pakistan.
Main Methods:
- DNA was extracted from 27 saliva samples of CVD patients.
- Mitochondrial Leucine Transfer RNA genes (MT-TL1 and MT-TL2) were amplified via polymerase chain reaction (PCR).
- PCR products underwent purification, sequencing, and alignment against the revised Cambridge Reference Sequence (rCRS).
Main Results:
- Sequencing and analysis revealed no alterations in the MT-TL1 and MT-TL2 genes within the studied patient samples.
- The investigated mitochondrial Leucine Transfer RNA genes did not show mutations in this cohort.
Conclusions:
- The study suggests that MT-TL1 and MT-TL2 genes may not be primary drivers of CVD in the studied Pakistani population.
- Larger population screening for mutations in mitochondrial-encoded Leucine Transfer RNA genes is recommended for Pakistani cardiac patients.
- Investigating other mitochondrial genes is advised for identifying potential genetic markers for early CVD detection in Pakistan.
Abstract:
Heart and blood vessel disorders, such as coronary heart disease, brain vessel disease, rheumatic heart disease, and others, are together referred to as cardiovascular disease (CVD). In this study, we sought to determine how mitochondrial Leucine Transfer RNA genes and CVDs are related (MT-L1 and MT-L2). From CVD patients in Peshawar, a total of 27 saliva samples were taken. Leu-tRNA genes expressed by mitochondria were amplified using polymerase chain reaction after DNA was removed. Ten samples were sent for sequencing after PCR and gene cleaning. We obtained all of the sequenced results, which were subsequently aligned and evaluated against the mitochondrial revised Cambridge Reference Sequence (rCRS). However, in our sequenced samples, Leu-tRNA MT-L1 and MT-L2 genes were determined to be unaltered. Thus, it is suggested that a large population be taken into account while screening for mutations in the mitochondrial encoded Leu-tRNA MT-L1 and MT-L2 genes of cardiac patients in areas of Pakistan. Additionally, it is recommended that patients with cardiac problems should also have other mitochondrial encoded genes checked for potential mutations. This could result in the identification of genetic markers that could be used for early CVD screening in Pakistan.
More Related Videos
Related Concept Videos
Animal Mitochondrial Genetics
Cardiomyopathy III: Hypertrophic Cardiomyopathy

